Oracle (NYSE:ORCL) Shares Down 1.7% After Analyst Downgrade

Oracle Corporation (NYSE:ORCLGet Free Report) shares dropped 1.7% on Tuesday after DA Davidson lowered their price target on the stock from $300.00 to $200.00. DA Davidson currently has a neutral rating on the stock. Oracle traded as low as $185.63 and last traded at $196.9260. Approximately 29,493,734 shares were traded during trading, an increase of 84% from the average daily volume of 16,036,073 shares. The stock had previously closed at $200.28.

Several other research firms have also issued reports on ORCL. Erste Group Bank lowered Oracle from a “buy” rating to a “hold” rating in a report on Monday, November 10th. Citigroup reissued a “buy” rating on shares of Oracle in a research report on Friday, October 10th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Oracle in a research report on Wednesday, November 19th. Evercore ISI lifted their target price on Oracle from $350.00 to $385.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. Finally, Robert W. Baird cut their price target on shares of Oracle from $365.00 to $315.00 and set an “outperform” rating on the stock in a report on Tuesday, November 18th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, ten have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Oracle has a consensus rating of “Moderate Buy” and a consensus price target of $319.40.

View Our Latest Analysis on Oracle

Insiders Place Their Bets

In related news, Director Jeffrey Berg sold 49,365 shares of the company’s stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $283.02, for a total transaction of $13,971,282.30. Following the sale, the director directly owned 151,999 shares in the company, valued at approximately $43,018,756.98. This represents a 24.52% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Naomi O. Seligman sold 2,222 shares of the firm’s stock in a transaction that occurred on Friday, September 26th. The stock was sold at an average price of $288.91, for a total transaction of $641,958.02. Following the completion of the transaction, the director directly owned 29,225 shares of the company’s stock, valued at approximately $8,443,394.75. This trade represents a 7.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 204,254 shares of company stock worth $60,227,807 in the last ninety days. 40.90% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oracle

Several institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Oracle by 2.8% during the third quarter. Vanguard Group Inc. now owns 168,960,500 shares of the enterprise software provider’s stock valued at $47,518,451,000 after buying an additional 4,681,626 shares during the period. State Street Corp grew its stake in Oracle by 1.7% during the second quarter. State Street Corp now owns 73,459,391 shares of the enterprise software provider’s stock valued at $16,060,427,000 after acquiring an additional 1,252,723 shares in the last quarter. Capital Research Global Investors increased its holdings in Oracle by 1.2% during the 3rd quarter. Capital Research Global Investors now owns 23,310,827 shares of the enterprise software provider’s stock worth $6,555,961,000 after acquiring an additional 266,588 shares during the period. Northern Trust Corp lifted its stake in Oracle by 0.6% in the 1st quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider’s stock worth $2,760,048,000 after purchasing an additional 120,889 shares in the last quarter. Finally, Norges Bank bought a new position in Oracle in the 2nd quarter valued at $4,275,378,000. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Oracle Price Performance

The firm has a market capitalization of $561.40 billion, a PE ratio of 45.58, a P/E/G ratio of 2.96 and a beta of 1.51. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The business’s 50 day moving average is $270.89 and its two-hundred day moving average is $237.13.

Oracle (NYSE:ORCLGet Free Report) last posted its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The company had revenue of $14.93 billion for the quarter, compared to the consensus estimate of $15.04 billion. During the same period in the prior year, the firm posted $1.39 earnings per share. The business’s revenue was up 12.2% on a year-over-year basis. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, research analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 23rd. Investors of record on Thursday, October 9th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is currently 46.30%.

Oracle Company Profile

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.